CCL4 and melanoma: In melanoma and HCC, a decrease in CCL4 and CCL5, leads to a defective recruitment of dendritic cells and consequently impaired T-cell activity and immune escape (Ruiz de Galarreta et al., 2019; Spranger et al., 2015).